Track Cel-Sci's total assets ($21B) with charts, peers, and YoY trends.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
As of the most recent data (June 2026), CVM shows a total assets of $21B. That compares with $20M in the prior-year period — up 104911.8% year over year. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, CVM's total assets is now $21B (was $20M) — a 104911.8% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Cel-Sci is outperforming or lagging.
Tracking CVM's total assets over time shows whether Cel-Sci is scaling, shrinking, or reshaping that part of the business. The current reading is $21B That compares with $20M in the prior-year period — up 104911.8% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this total assets page, Stockcircle has Cel-Sci's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total assets (currently $21B) with ownership activity and broader fundamentals.
Cel-Sci's total assets is $21B; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.